Short-Term Anticoagulation After Cardioversion in New-Onset Atrial Fibrillation and Low Thromboembolic Risk: A Real-World International Investigation

Alan Poggio, Andrew P. Sullivan, Lorenzo Rampa, Jason G. Andrade, Matteo Anselmino

Open source

DOI
10.3390/medicina61071200
Published
2025-06-30
Container
Medicina
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medicina61071200,
  title = {Short-Term Anticoagulation After Cardioversion in New-Onset Atrial Fibrillation and Low Thromboembolic Risk: A Real-World International Investigation},
  author = {Alan Poggio and Andrew P. Sullivan and Lorenzo Rampa and Jason G. Andrade and Matteo Anselmino},
  year = {2025},
  journal = {Medicina},
  doi = {10.3390/medicina61071200},
  url = {https://doi.org/10.3390/medicina61071200}
}

RIS

TY  - JOUR
TI  - Short-Term Anticoagulation After Cardioversion in New-Onset Atrial Fibrillation and Low Thromboembolic Risk: A Real-World International Investigation
AU  - Alan Poggio
AU  - Andrew P. Sullivan
AU  - Lorenzo Rampa
AU  - Jason G. Andrade
AU  - Matteo Anselmino
PY  - 2025
JO  - Medicina
DO  - 10.3390/medicina61071200
UR  - https://doi.org/10.3390/medicina61071200
ER  - 

APA

Poggio, A., Sullivan, A. P., Rampa, L., Andrade, J. G., & Anselmino, M. (2025). Short-Term Anticoagulation After Cardioversion in New-Onset Atrial Fibrillation and Low Thromboembolic Risk: A Real-World International Investigation. Medicina. https://doi.org/10.3390/medicina61071200

Source records